How has been the historical performance of Natural Biocon?

Answer:The historical performance of Natural Biocon shows a fluctuating trend in its financial metrics over the years.

Breakdown:
Natural Biocon's net sales have seen significant growth from Mar'20, where it reported no sales, to Mar'25 with sales of 8.35 Cr, although this is a decline from the previous year's sales of 13.53 Cr. The total operating income followed a similar pattern, increasing from 0.00 Cr in Mar'20 to 8.35 Cr in Mar'25, but also down from 13.53 Cr in Mar'24. The company's total expenditure, excluding depreciation, rose from 0.03 Cr in Mar'20 to 8.29 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) peaked at 0.24 Cr in Mar'23 but fell to 0.06 Cr in Mar'25. Profit before tax also decreased from 0.25 Cr in Mar'23 to 0.06 Cr in Mar'25, while profit after tax dropped to 0.04 Cr in Mar'25 from 0.15 Cr in Mar'24. The company's equity capital increased significantly to 25.78 Cr in Mar'25 from 11.37 Cr in Mar'24, and total assets rose to 38.52 Cr in Mar'25 from 16.77 Cr in Mar'24. However, total liabilities also increased, reaching 38.52 Cr in Mar'25. The cash flow from operating activities was positive at 1.00 Cr in Mar'25, while cash flow from investing activities was negative at -21.00 Cr, indicating significant investments. Overall, Natural Biocon's financial performance reflects both growth and challenges in profitability and operational efficiency over the years.